Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation
Author(s) -
Oriana Simonetti,
Oscar Cirioni,
Guendalina Lucarini,
Fiorenza Orlando,
Roberto Ghiselli,
Carmela Silvestri,
Lucia Brescini,
Marco Rocchi,
Mauro Provinciali,
Mario Guerrieri,
Roberto Di Primio,
Andrea Giacometti,
A. Offidani
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr440
Subject(s) - teicoplanin , tigecycline , medicine , staphylococcus aureus , antibiotics , wound healing , microbiology and biotechnology , antimicrobial , surgery , pharmacology , vancomycin , biology , bacteria , genetics
We investigated the in vivo efficacy of tigecycline, a new glycylcycline (a tetracycline derivative), in the management of methicillin-resistant Staphylococcus aureus (MRSA)-infected experimental surgical wounds in rats. The main outcome measures were quantitative bacterial culture, histological examination and immunohistochemical expression of matrix metalloproteinase-9 (MMP-9) and collagen IV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom